Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study (Q57053392)
Jump to navigation
Jump to search
scientific article published on 10 July 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study |
scientific article published on 10 July 2003 |
Statements
Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study (English)
Lindsey R Baden
Joseph H Antin
Michelle M Fahey
Edwin P Alyea
Robert J Soiffer